The Epstein-Barr Virus lytic life cycle

DNA Tumor Viruses

Volumn , Issue , 2009, Pages 285-315

  Swaminathan, Sankar ^a   Kenney, Shannon ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78049405574     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-68945-6_13     Document Type: Chapter

References (232)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. and Kenney, S. (2000) Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c- Jun N-terminal kinases. J Virol. 74, 1224-1233.
2. Adamson, A. L. and Kenney, S. (2001) Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodies.J Virol. 75, 2388-2399.
3. Adamson, A. L. and Kenney, S. (1999) The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol. 73, 6551-6558.
4. Adamson, A. L. and Kenney, S. C. (1998) Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.Virology. 251, 187-197.
5. Albrecht, J. C., Nicholas, J., Billler, D., Cameron, K. R., Beisinger, B. C. N., Wittman, S., Craxton, M. A. and Coleman, H. (1992) Primary structure of the herpesvirus saimiri genome. J. Virol. 66, 5047-5058.
6. Altmann, M. and Hammerschmidt, W. (2005) Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis. PLoS Biology. 3, e404.
7. Ambinder, R. F., Robertson, K. D. and Tao, Q. (1999) DNA methylation and the Epstein- Barr virus.Semin Cancer Biol. 9, 369-375.
8. Asai, R., Kato, A., Kato, K., Kanamori-Koyama, M., Sugimoto, K., Sairenji, T., Nishiyama, Y. and Kawaguchi, Y. (2006) Epstein-Barr Virus Protein Kinase BGLF4 is a Virion tegument protein that dissociates from Virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J. Virol. 80, 5125-5134.
9. Baran-Marszak, F., Feuillard, J., Najjar, I., Le Clorennec, C., Bechet, J. M., Dusanter-Fourt, I., Bornkamm, G. W., Raphael, M. and Fagard, R. (2004) Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood. 104, 2475-2483.
10. Batisse, J., Manet, E., Middeldorp, J., Sergeant, A. and Gruffat, H. (2005) Epstein-Barr virus mRNA export factor EB2 is essential for intranuclear capsid assembly and production of gp350. J Virol. 79, 14102-14111.
11. Baumann, M., Feederle, R., Kremmer, E. and Hammerschmidt, W. (1999) Cellular transcription factors recruit viral replication proteins to activate the Epstein-Barr virus origin of lytic DNA replication, oriLyt. Embo J. 18, 6095-6105.
12. Baumann, M., Mischak, H., Dammeier, S., Kolch, W., Gires, O., Pich, D., Zeidler, R., Delecluse, H. J. and Hammerschmidt, W. (1998) Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation. J Virol. 72, 8105-8114.
13. Bell, P., Lieberman, P. M. and Maul, G. G. (2000) Lytic but not latent replication of epsteinbarr virus is associated with PML and induces sequential release of nuclear domain 10 proteins. J Virol. 74, 11800-11810.
14. Bello, L. J., Davison, A. J., Glenn, M. A., Whitehouse, A., Rethmeier, N., Schulz, T. F. and Barklie Clements, J. (1999) The human herpesvirus-8 ORF 57 gene and its properties. J Gen Virol. 80, 3207-3215.
15. Bellows, D. S., Howell, M., Pearson, C., Hazlewood, S. A. and Hardwick, J. M. (2002) Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol. 76, 2469-2479.
16. Bhende, P. M., Dickerson, S. J., Sun, X., Feng, W.-h. and Kenney, S. C. (2007) X-box-binding protein 1 (XBP-1) activates lytic Epstein-Barr virus gene expression in combination with Protein Kinase D (PKD). J. Virol. JVI. 00154-00107.
17. Bhende, P. M., Seaman, W. T., Delecluse, H. J. and Kenney, S. C. (2005) BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol. 79, 7338-7348.
18. Bhende, P. M., Seaman, W. T., Delecluse, H. J. and Kenney, S. C. (2004) The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet. 36, 1099-1104.
19. Biggin, M., Bodescot, M., Perricaudet, M. and Farrell, P. (1987) Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J. Virol. 61, 3120-3132.
20. Binne, U. K., Amon, W. and Farrell, P. J. (2002) Promoter sequences required for reactivation of Epstein-Barr virus from latency. J Virol. 76, 10282-10289.
21. Borras, A. M., Strominger, J. L. and Speck, S. H. (1996) Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction. J Virol. 70, 3894-3901.
22. Boyle, S. M., Ruvolo, V., Gupta, A. K. and Swaminathan, S. (1999) Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene expression. J Virol. 73, 6872-6881.
23. Bryant, H. and Farrell, P. J. (2002) Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency. J Virol. 76, 10290-10298.
24. Buisson, M., Hans, F., Kusters, I., Duran, N. and Sergeant, A. (1999) The C-terminal region but not the Arg-X-Pro repeat of Epstein-Barr virus protein EB2 is required for its effect on RNA splicing and transport. J Virol. 73, 4090-4100.
25. Buisson, M., Manet, E., Trescol-Biemont, M. C., Gruffat, H., Durand, B. and Sergeant, A. (1989) The Epstein-Barr Virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R. J. Virol. 63 (12), 5276-5284.
26. Cai, X., Schafer, A., Lu, S., Bilello, J. P., Desrosiers, R. C., Edwards, R., Raab-Traub, N. and Cullen, B. R. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2, e23.
27. Cayrol, C. and Flemington, E. (1996) G0/G1 growth arrest mediated by a region encompassing the basic leucine zipper (bZIP) domain of the Epstein-Barr virus transactivator Zta. J Biol Chem. 271, 31799-31802.
28. Cayrol, C. and Flemington, E. K. (1995) Identification of cellular target genes of the Epstein- Barr virus transactivator Zta: Activation of transforming growth factor beta igh3 (TGFbeta igh3) and TGF-beta 1. J Virol. 69, 4206-4212.
29. Cayrol, C. and Flemington, E. K. (1996) The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors. Embo J. 15, 2748-2759.
30. Chang, L. K., Chung, J. Y., Hong, Y. R., Ichimura, T., Nakao, M., Liu, S. T. (2005) Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1. Nucleic Acids Res. 33(20), 6528-39.
31. Chang, Y. N., Dong, D. L., Hayward, G. S. and Hayward, S. D. (1990) The Epstein-Barr virus Zta transactivator: A member of the bZIP family with unique DNA-binding specificity and a dimerization domain that lacks the characteristic heptad leucine zipper motif. J Virol. 64, 3358-3369.
32. Chapman, C. J., Harris, J. D., Hardwicke, M. A., Sandri-Goldin, R. M., Collins, M. K. and Latchman, D. S. (1992) Promoter-independent activation of heterologous virus gene expression by the herpes simplex virus immediate-early protein ICP27. Virology. 186, 573-578.
33. Chatila, T., Ho, N., Liu, P., Liu, S., Mosialos, G., Kieff, E. and Speck, S. H. (1997) The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication. J Virol. 71, 6560-6567.
34. Chee, M. and Barrell, B. (1990) Herpesviruses: A study of parts. Trends Genet. 6, 86-91.
35. Chen, C. J., Deng, Z., Kim, A. Y., Blobel, G. A. and Lieberman, P. M. (2001) Stimulation of CREB binding protein nucleosomal histone acetyltransferase activity by a class of transcriptional activators. Mol Cell Biol. 21, 476-487.
36. Chen, L., Liao, G., Fujimuro, M., Semmes, O. J. and Hayward, S. D. (2001) Properties of two EBV Mta nuclear export signal sequences. Virology. 288, 119-128.
37. Chen, M.-R., Chang, S.-J., Huang, H. and Chen, J.-Y. (2000) A Protein Kinase Activity Associated with Epstein-Barr Virus BGLF4 Phosphorylates the Viral Early Antigen EAD In Vitro. J. Virol. 74, 3093-3104.
38. Chen, M. R., Chang, S. J., Huang, H. and Chen, J. Y. (2000) A protein kinase activity associated with Epstein-Barr virus BGLF4 phosphorylates the viral early antigen EA-D in vitro. J Virol. 74, 3093-3104.
39. Cheng, H., Dufu, K., Lee, C. S., Hsu, J. L., Dias, A. and Reed, R. (2006) Human mRNA export machinery recruited to the 50 end of mRNA. Cell. 127, 1389-1400.
40. Chevallier-Greco, A., Gruffat, H., Manet, E., Calender, A. and Sergeant, A. (1989)The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protein R. J Virol. 63, 615-623.
41. Chi, T. and Carey, M. (1993) The ZEBRA activation domain: modular organization and mechanism of action. Mol Cell Biol. 13, 7045-7055.
42. Chi, T., Lieberman, P., Ellwood, K. and Carey, M. (1995) A general mechanism for transcriptional synergy by eukaryotic activators. Nature. 377, 254-257.
43. Chua, H. H., Lee, H. H., Chang, S. S., Lu, C. C., Yeh, T. H., Hsu, T. Y., Cheng, T. H., Cheng, J. T., Chen, M. R. and Tsai, C. H. (2007) Role of the TSG101 gene in Epstein-Barr virus late gene transcription. J Virol. 81, 2459-2471.
44. Cohen, J. I. (2000) Epstein-Barr virus infection. N Engl J Med. 343, 481-492.
45. Cohen, J. I. and Lekstrom, K. (1999) Epstein-Barr Virus BARF1 Protein Is Dispensable for B-Cell Transformation and Inhibits Alpha Interferon Secretion from Mononuclear Cells. J. Virol. 73, 7627-7632.
46. Countryman, J., Jenson, H., Seibl, R., Wolf, H. and Miller, G. (1987) Polymorphic proteins encoded within BZLF1 of defective and standard Epstein-Barr viruses disrupt latency. J Virol. 61, 3672-3679.
47. Countryman, J. and Miller, G. (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proceedings of the National Academy of Sciences of the United States of America. 82, 4085-4089.
48. Countryman, J. and Miller, G. (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci USA. 82, 4085-4089.
49. Cox, M. A., Leahy, J. and Hardwick, J. M. (1990) An enhancer within the divergent promoter of Epstein-Barr virus responds synergistically to the R and Z transactivators. J Virol. 64, 313-321.
50. Daibata, M., Humphreys, R. E. and Sairenji, T. (1992) Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA. Virology. 188, 916-920.
51. Daibata, M., Speck, S. H., Mulder, C. and Sairenji, T. (1994) Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells. Virology. 198, 446-454.
52. Darr, C. D., Mauser, A. and Kenney, S. (2001) Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol- 3 kinase activation. J Virol. 75, 6135-6142.
53. Deng, Z., Chen, C. J., Chamberlin, M., Lu, F., Blobel, G. A., Speicher, D., Cirillo, L. A., Zaret, K. S. and Lieberman, P. M. (2003) The CBP bromodomain and nucleosome targeting are required for Zta-directed nucleosome acetylation and transcription activation. Mol Cell Biol. 23, 2633-2644.
54. Deng, Z., Chen, C. J., Zerby, D., Delecluse, H. J. and Lieberman, P. M. (2001) Identification of acidic and aromatic residues in the Zta activation domain essential for Epstein-Barr virus reactivation. J Virol. 75, 10334-10347.
55. El-Guindy A H. L., Delecluse HJ, Miller G. (2007) Phosphoacceptor site S173 in the regulatory domain of Epstein-Barr Virus ZEBRA protein is required for lytic DNA replication but not for activation of viral early genes. J Virol. 81(7), 3303-3316.
56. El-Guindy, A. S., Heston, L., Endo, Y., Cho, M. S. and Miller, G. (2002) Disruption of Epstein-Barr virus latency in the absence of phosphorylation of ZEBRA by protein kinase C. J Virol. 76, 11199-11208.
57. Faggioni, A., Zompetta, C., Grimaldi, S., Barile, G., Frati, L. and Lazdins, J. (1986) Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science. 232, 1554-1556.
58. Fahmi, H., Cochet, C., Hmama, Z., Opolon, P. and Joab, I. (2000) Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J Virol. 74, 5810-5818.
59. Falk, K. I. and Ernberg, I. (1999) Demethylation of the Epstein-barr virus origin of lytic replication and of the immediate early gene BZLF1 is DNA replication independent. Brief report. Arch Virol. 144, 2219-2227.
60. Farina, A., Feederle, R., Raffa, S., Gonnella, R., Santarelli, R., Frati, L., Angeloni, A., Torrisi, M. R., Faggioni, A. and Delecluse, H. J. (2005) BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. J Virol. 79, 3703-3712.
61. Farrell, P. J., Rowe, D. T., Rooney, C. M. and Kouzarides, T. (1989) Epstein-Barr virus BZLF1 transactivator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J. 8, 127-132.
62. Feederle, R., Kost, M., Baumann, M., Janz, A., Drouet, E., Hammerschmidt, W. and Delecluse, H. J. (2000) The Epstein-Barr virus lytic program is controlled by the cooperative functions of two transactivators. Embo J. 19, 3080-3089.
63. Feederle, R., Neuhierl, B., Baldwin, G., Bannert, H., Hub, B., Mautner, J., Behrends, U. and Delecluse, H. J. (2006) Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J Virol. 80, 9435-9443.
64. Feederle, R., Neuhierl, B., Bannert, H., Geletneky, K., Shannon-Lowe, C. and Delecluse, H. J. (2007) Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. 121, 588-594.
65. Feng W. H.C. J., Fischer S., Li L., Sneller M., Goldbach-Mansky R., Raab-Traub N., Delecluse H. J., Kenney S .C. (2004a) Reactivation of latent Epstein-Barr virus by methotrexate: A potential contributor to methotrexate-associated lymphomas. J Natl Cancer Inst. 96(22), 1691-1702.
66. Feng, W. H., Hong, G., Delecluse, H. J. and Kenney, S. C. (2004b) Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas. J Virol. 78, 1893-1902.
67. Feng, W. H., Israel, B., Raab-Traub, N., Busson, P. and Kenney, S. C. (2002) Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res. 62, 1920-1926.
68. Feng, W. H. and Kenney, S. C. (2006) Valproic Acid Enhances the Efficacy of Chemotherapy in EBV-Positive Tumors by Increasing Lytic Viral Gene Expression. 66, 8762-8769.
69. Fitz, L. J., Morris, J. C., Towler, P., Long, A., Burgess, P., Greco, R., Wang, J., Gassaway, R., Nickbarg, E., Kovacic, S., Ciarletta, A., Giannotti, J., Finnerty, H., Zollner, R., Beier, D. R., Leak, L. V., Turner, K. J. and Wood, C. R. (1997) Characterization of murine Flt4 ligand/VEGF-C. Oncogene. 15, 613-618.
70. Fixman, E. D., Hayward, G. S. and Hayward, S. D. (1995) Replication of Epstein-Barr virus oriLyt: lack of a dedicated virally encoded origin-binding protein and dependence on Zta in cotransfection assays. J. Virol. 69, 2998-3006.
71. Fixman, E. D., Hayward, G. S. and Hayward, S. D. (1992) trans-acting requirements for replication of Epstein-Barr virus ori-lyt. J. Virol. 66, 5030-5039.
72. Flamand, L. and Menezes, J. (1996) Cyclic AMP-responsive element-dependent activation of Epstein-Barr virus zebra promoter by human herpesvirus 6. J Virol. 70, 1784-1791.
73. Flemington, E. and Speck, S. H. (1990a) Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 64, 1227-1232.
74. Flemington, E. and Speck, S. H. (1990b) Epstein-Barr virus BZLF1 trans activator induces the promoter of a cellular cognate gene, c-fos. J Virol. 64, 4549-4552.
75. Flemington, E. and Speck, S. H. (1990c) Evidence for coiled-coil dimer formation by an Epstein-Barr virus transactivator that lacks a heptad repeat of leucine residues. Proc Natl Acad Sci USA. 87, 9459-9463.
76. Flemington, E. and Speck, S. H. (1990) Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. 64, 1217-1226.
77. Flemington, E. K., Borras, A. M., Lytle, J. P. and Speck, S. H. (1992) Characterization of the Epstein-Barr virus BZLF1 protein transactivation domain. J Virol. 66, 922-929.
78. Flemington, E. K., Goldfeld, A. E. and Speck, S. H. (1991) Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol. 65, 7073-7077.
79. Flemington, E. K., Lytle, J. P., Cayrol, C., Borras, A. M. and Speck, S. H. (1994) DNAbinding- defective mutants of the Epstein-Barr virus lytic switch activator Zta transactivate with altered specificities. Mol Cell Biol. 14, 3041-3052.
80. Francis, A., Ragoczy, T., Gradoville, L., Heston, L., El-Guindy, A., Endo, Y. and Miller, G. (1999) Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator. J Virol. 73, 4543-4551.
81. Francis, A. L., Gradoville, L. and Miller, G. (1997) Alteration of a single serine in the basic domain of the Epstein-Barr virus ZEBRA protein separates its functions of transcriptional activation and disruption of latency. J Virol. 71, 3054-3061.
82. Fu, D. X., Tanhehco, Y. C., Chen, J., Foss, C. A., Fox, J. J., Lemas, V., Chong, J. M., Ambinder, R. F. and Pomper, M. G. (2007) Virus-associated tumor imaging by induction of viral gene expression. Clin Cancer Res. 13, 1453-1458.
83. Fujii, K., Yokoyama, N., Kiyono, T., Kuzushima, K., Homma, M., Nishiyama, Y., Fujita, M. and Tsurumi, T. (2000) The Epstein-Barr Virus Pol Catalytic Subunit Physically Interacts with the BBLF4-BSLF1-BBLF2/3 Complex. J. Virol. 74, 2550-2557.
84. Funch D. P. W. A., Schneider G., Ziyadeh N. J., Pescovitz M. D. (2005) Ganciclovir and acyclovir reduce the risk of post-transplant lymphoproliferative disorder in renal transplant recipients. Am J Transplant. 5(12), 2894-2900.
85. Gao, Z., Krithivas, A., Finan, J. E., Semmes, O. J., Zhou, S., Wang, Y. and Hayward, S. D. (1998) The Epstein-Barr virus lytic transactivator Zta interacts with the helicase-primase replication proteins. J Virol. 72, 8559-8567.
86. Gershburg, E., Marschall, M., Hong, K. and Pagano, J. S. (2004) Expression and Localization of the Epstein-Barr Virus-Encoded Protein Kinase. J. Virol. 78, 12140-12146.
87. Gershburg, E. and Pagano, J. S. (2002) Phosphorylation of the Epstein-Barr Virus (EBV) DNA Polymerase Processivity Factor EA-D by the EBV-Encoded Protein Kinase and Effects of the L-Riboside Benzimidazole 1263W94. J. Virol. 76, 998-1003.
88. Gershburg, E., Raffa, S., Torrisi, M. R. and Pagano, J. S. (2007) Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus. J. Virol. 81, 5407-5412.
89. Gonnella, R., Farina, A., Santarelli, R., Raffa, S., Feederle, R., Bei, R., Granato, M., Modesti, A., Frati, L., Delecluse, H. J., Torrisi, M. R., Angeloni, A. and Faggioni, A. (2005) Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. J Virol. 79, 3713-3727.
90. Gradoville, L., Kwa, D., El-Guindy, A. and Miller, G. (2002) Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.J Virol. 76, 5612-5626.
91. Granzow, H., Klupp, B. G., Fuchs, W., Veits, J., Osterrieder, N. and Mettenleiter, T. C. (2001) Egress of alphaherpesviruses: comparative ultrastructural study. J Virol. 75, 3675-3684.
92. Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V. and Freese, U. K. (1985) Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N Engl J Med. 313, 1564-1571.
93. Gruffat, H., Batisse, J., Pich, D., Neuhierl, B., Manet, E., Hammerschmidt, W. and Sergeant, A. (2002) Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus. J Virol. 76, 9635-9644.
94. Gruffat, H., Duran, N., Buisson, M., Wild, F., Buckland, R. and Sergeant, A. (1992) Characterization of an R-binding site mediating the R-induced activation of the Epstein-Barr virus BMLF1 promoter. J Virol. 66, 46-52.
95. Gruffat, H., Manet, E., Rigolet, A. and Sergeant, A. (1990) The enhancer factorR of Epstein-Barr virus (EBV) is a sequence specific DNA binding protein. Nucleic Acids Res. 18, 6835-66843.
96. Gruffat, H., Manet, E. and Sergeant, A. (2002) MEF2-mediated recruitment of class II HDAC at the EBV immediate early gene BZLF1 links latency and chromatin remodeling. EMBO Rep. 3, 141-146.
97. Gruffat, H. and Sergeant, A. (1994) Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res. 22, 1172-1178.
98. Grundhoff, A., Sullivan, C. S. and Ganem, D. (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gammaherpesviruses. Rna. 12, 733-750.
99. Gupta, A. K., Ruvolo, V., Patterson, C. and Swaminathan, S. (2000) The human herpesvirus 8 homolog of Epstein-Barr virusSM protein (KS- SM) is a posttranscriptional activator of gene expression. J Virol. 74, 1038-1044.
100. Hahn, A. M., Huye L. E., Ning, S., Webster-Cyriaque, J., Pagano, J. S. (2005) Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1. J Virol. 79 10040-10052.
101. Hammerschmidt, W. and Sugden, B. (1988) Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus. Cell. 55, 427-433.
102. Han, Z., Marendy, E., Wang, Y. D., Yuan, J., Sample, J. T. and Swaminathan, S. (2007) Multiple roles of Epstein-Barr virus SM protein in lytic replication. J Virol. 81, 4058-4069.
103. Hardwick, J. M., Lieberman, P. M. and Hayward, S. D. (1988) A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen. J Virol. 62, 2274-2284.
104. Hardwick, J. M., Tse, L., Applegren, N., Nicholas, J. and Veliuona, M. A. (1992) The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16. J Virol. 66, 5500-5508.
105. Henderson, S., Huen, D., Rowe, M., Dawson, C., Johnson, G. and Rickinson, A. (1993) Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc Natl Acad Sci USA. 90, 8479-8483.
106. Heston, L., El-Guindy, A., Countryman, J., Dela Cruz, C., Delecluse, H. J. and Miller, G. (2006) Amino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication. J Virol. 80(18), 9115-9133.
107. Hiriart, E., Bardouillet, L., Manet, E., Gruffat, H., Penin, F., Montserret, R., Farjot, G. and Sergeant, A. (2003) A region of the Epstein-Barr virus (EBV) mRNA export factor EB2 containing an arginine-rich motif mediates direct binding to RNA. J Biol Chem. 278, 37790-37798.
108. Hiriart, E., Farjot, G., Gruffat, H., Nguyen, M. V., Sergeant, A. and Manet, E. (2003)Anovel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein. J Biol Chem. 278, 335-342.
109. Hiriart, E., Gruffat, H., Buisson, M., Mikaelian, I., Keppler, S., Meresse, P., Mercher, T., Bernard, O. A., Sergeant, A. and Manet, E. (2005) Interaction of the Epstein-Barr virus mRNAexport factor EB2 with human Spen proteins SHARP, OTT1, and a novel member of the family, OTT3, links Spen proteins with splicing regulation andmRNAexport. J Biol Chem. 280, 36935-36945.
110. Ho, C.H., Hsu C.-F., Fong, P.F., Tai, S.K., Hsieh, S.L. and Chen, C.J. Related Articles, (2007) Epstein-Barr virus transcription activator Rta upregulates decoy receptor 3 expression by binding to its promoter. J Virol. 81(9), 4837-4847.
111. Holley-Guthrie, E. A., Quinlivan, E. B., Mar, E. C. and Kenney, S. (1990) The Epstein-Barr virus (EBV) BMRF1 promoter for early antigen (EA-D) is regulated by the EBV transactivators, BRLF1 and BZLF1, in a cell-specific manner. J Virol. 64, 3753-3759.
112. Hong, G. K., Delecluse, H.-J., Gruffat, H., Morrison, T. E., Feng, W. H., Sergeant, A. and Kenney, S. C. (2004) The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. J Virol. 78(10), 4983-92.
113. Hong, G. K., Gulley, M. L., Feng, W. H., Delecluse, H. J., Holley-Guthrie, E. and Kenney, S. C. (2005) Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model. J Virol. 79, 13993-14003.
114. Hong, G. K., Kumar, P., Wang, L., Damania, B., Gulley, M. L., Delecluse, H. J., Polverini, P. J. and Kenney, S. C. (2005) Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J Virol. 79, 13984-13992.
115. Hsu, D., De Waal Malefyt, R., Fiorentino, D., Dang, M., Vieira, P., Devries, J., Spits, H., Mosmann, T. and Moore, K. (1990) Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science. 250, 830-832.
116. Jenkins, P. J., Binne, U. K. and Farrell, P. J. (2000) Histone acetylation and reactivation of Epstein-Barr virus from latency. J Virol. 74, 710-720.
117. Johannsen, E., Luftig, M., Chase, M. R., Weicksel, S., Cahir-McFarland, E., Illanes, D., Sarracino, D. and Kieff, E. (2004) Proteins of purified Epstein-Barr virus. Proc Natl Acad Sci USA. 101, 16286-16291.
118. Jones, R. J., Seaman, W. T., Feng, W. H., Barlow, E., Dickerson, S., Delecluse, H. J. and Kenney, S. C. (2007) Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer. 121(6), 1274-81.
119. Karimi, L., Crawford, D. H., Speck, S. and Nicholson, L. J. (1995) Identification of an epithelial cell differentiation responsive region within the BZLF1 promoter of the Epstein-Barr virus. J Gen Virol. 76 (Pt 4), 759-765.
120. Kato, K., Yokoyama, A., Tohya, Y., Akashi, H., Nishiyama, Y. and Kawaguchi, Y. (2003) Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function. J Gen Virol. 84, 3381-3392.
121. Keating, S., Prince, S., Jones, M. and Rowe, M. (2002) The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules. J Virol. 76, 8179-8188.
122. Kenney, S., Holley-Guthrie, E., Mar, E. C. and Smith, M. (1989) The Epstein-Barr Virus BMLF1 promoter contains an enhancer element that is responsive to the BZLF1 and BRLF1 transactivators. J. Virol. 63, 3878-3883.
123. Key, S. C., Yoshizaki, T. and Pagano, J. S. (1998) The Epstein-Barr virus (EBV) SM protein enhances pre-mRNA processing of the EBV DNA polymerase transcript. J Virol. 72, 8485-8492.
124. Klupp, B. G., Granzow, H., Fuchs, W., Keil, G. M., Finke, S. and Mettenleiter, T. C. (2007) Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins. Proc Natl Acad Sci USA. 104, 7241-7246.
125. Kouzarides, T., Packham, G., Cook, A. and Farrell, P. J. (1991) The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene. 6, 195-204.
126. Kraus, R. J., Mirocha, S. J., Stephany, H. M., Puchalski, J. R. and Mertz, J. E. (2001) Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus. J Virol. 75, 867-877.
127. Kraus, R. J., Perrigoue, J. G. and Mertz, J. E. (2003) ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J Virol. 77, 199-207.
128. Kudoh, A., Daikoku, T., Sugaya, Y., Isomura, H., Fujita, M., Kiyono, T., Nishiyama, Y. and Tsurumi, T. (2004) Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication. J Virol. 78, 104-115.
129. Kudoh, A., Fujita, M., Kiyono, T., Kuzushima, K., Sugaya, Y., Izuta, S., Nishiyama, Y. and Tsurumi, T. (2003) Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication. J Virol. 77, 851-861.
130. Laichalk, L. L. and Thorley-Lawson, D. A. (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. 79, 1296-1307.
131. Le Roux, F., Sergeant, A. and Corbo, L. (1996) Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. J Gen Virol. 77 (Pt 3), 501-509.
132. Lebedev, A. A., Krause, M. H., Isidro, A. L., Vagin, A. A., Orlova, E. V., Turner, J., Dodson, E. J., Tavares, P. and Antson, A. A. (2007) Structural framework for DNA translocation via the viral portal protein. Embo J. 26, 1984-1994.
133. Lee, C. P., Chen, J. Y., Wang, J. T., Kimura, K., Takemoto, A., Lu, C. C. and Chen, M. R. (2007) Epstein-Barr Virus BGLF4 Kinase Induces Premature Chromosome Condensation through Activation of Condensin and Topoisomerase II. J Virol. 81, 5166-5180.
134. Lee, M. A. and Yates, J. L. (1992) BHRF1 of Epstein-Barr virus, which is homologous to human proto-oncogene bcl2, is not essential for transformation of B cells or for virus replication in vitro. J Virol. 66, 1899-1906.
135. Li, Y., Webster-Cyriaque, J., Tomlinson, C. C., Yohe, M. and Kenney, S. (2004) Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and required for lytic viral gene expression. J Virol. 78(8), 4197-206.
136. Liang, C. L., Chen, J. L., Hsu, Y. P., Ou, J. T. and Chang, Y. S. (2002) Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins. J Biol Chem. 277, 23345-23357.
137. Liao, G., Huang, J., Fixman, E. D. and Hayward, S. D. (2005) The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor. J Virol. 79, 245-256.
138. Lieberman, P. M. and Berk, A. J. (1994) A mechanism for TAFs in transcriptional activation: Activation domain enhancement of TFIID-TFIIA-promoter DNA complex formation. Genes Dev. 8, 995-1006.
139. Lieberman, P. M. and Berk, A. J. (1990) In vitro transcriptional activation, dimerization, and DNA-binding specificity of the Epstein-Barr virus Zta protein. J Virol. 64, 2560-2568.
140. Lieberman, P. M. and Berk, A. J. (1991) The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev. 5, 2441-2454.
141. Lieberman, P. M., Hardwick, J. M. and Hayward, S. D. (1989) Responsiveness of the Epstein- Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions. J Virol. 63, 3040-3050.
142. Lieberman, P. M., Hardwick, J. M., Sample, J., Hayward, G. S. and Hayward, S. D. (1990) The zta transactivator involved in induction of lytic cycle gene expression in Epstein-Barr virus-infected lymphocytes binds to both AP-1 and ZRE sites in target promoter and enhancer regions. J Virol. 64, 1143-1155.
143. Lieberman, P. M., Ozer, J. and Gursel, D. B. (1997) Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition. Mol Cell Biol. 17, 6624-6632.
144. Ling, P. D., Lednicky, J. A., Keitel, W. A., Poston, D. G., White, Z. S., Peng, R., Liu, Z., Mehta, S. K., Pierson, D. L., Rooney, C. M., Vilchez, R. A., Smith, E. O. and Butel, J. S. (2003) The dynamics of herpesvirus and polyomavirus reactivation and shedding in healthy adults: A 14-month longitudinal study. J Infect Dis. 187, 1571-1580.
145. Liou, H. C., Boothby, M. R., Finn, P. W., Davidon, R., Nabavi, N., Zeleznik-Le, N. J., Ting, J. P. and Glimcher, L. H. (1990) A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science. 247, 1581-1584.
146. Liu, P., Liu, S. and Speck, S. H. (1998) Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter. J Virol. 72, 8230-8239.
147. Liu, P. and Speck, S. H. (2003) Synergistic autoactivation of the Epstein-Barr virus immediate- early BRLF1 promoter by Rta and Zta. Virology. 310, 199-206.
148. Lu, C. C., Jeng, Y. Y., Tsai, C. H., Liu, M. Y., Yeh, S. W., Hsu, T. Y. and Chen, M. R. (2006) Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology. 345, 358-372.
149. Lu, J., Chen, S. Y., Chua, H. H., Liu, Y. S., Huang, Y. T., Chang, Y., Chen, J. Y., Sheen, T. S. and Tsai, C. H. (2000) Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta. J Virol. 74, 7391-7399.
150. Lu, J., Chua, H. H., Chen, S. Y., Chen, J. Y. and Tsai, C. H. (2003) Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. Cancer Res. 63, 256-262.
151. MacCallum, P., Karimi, L. and Nicholson, L. J. (1999) Definition of the transcription factors which bind the differentiation responsive element of the Epstein-Barr virus BZLF1 Z promoter in human epithelial cells. J Gen Virol. 80 (Pt 6), 1501-1512.
152. Mahot, S., Sergeant, A., Drouet, E. and Gruffat, H. (2003) A novel function for the Epstein- Barr virus transcription factor EB1/Zta: induction of transcription of the hIL-10 gene. J Gen Virol. 84, 965-974.
153. Manet, E., Allera, C., Gruffat, H., Mikaelian, I., Rigolet, A. and Sergeant, A. (1993) The acidic activation domain of the Epstein-Barr virus transcription factor R interacts in vitro with both TBP and TFIIB and is cell-specifically potentiated by a proline-rich region. Gene Expr. 3, 49-59.
154. Manet, E., Rigolet, A., Gruffat, H., Giot, J. F. and Sergeant, A. (1991) Domains of the Epstein-Barr virus (EBV) transcription factor R required for dimerization, DNA binding and activation. Nucleic Acids Res. 19, 2661-2667.
155. Marchini, A., Tomkinson, B., Cohen, J. I. and Kieff, E. (1991) BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication. J. Virol. 5991-6000.
156. Marshall, W. L., Yim, C., Gustafson, E., Graf, T., Sage, D. R., Hanify, K., Williams, L., Fingeroth, J. and Finberg, R. W. (1999) Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol. 73, 5181-5185.
157. Matthews, R. P., Guthrie, C. R., Wailes, L. M., Zhao, X., Means, A. R. and McKnight, G. S. (1994) Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol Cell Biol. 14, 6107-6116.
158. Maul, G. G. (1998) Nuclear domain 10, the site of DNA virus transcription and replication. BioEssays. 20, 660-667.
159. Mauser, A., Holley-Guthrie, E., Simpson, D., Kaufmann, W. and Kenney, S. (2002) The Epstein-Barr virus immediate-early protein BZLF1 induces both a G(2) and a mitotic block. J Virol. 76, 10030-10037.
160. Mauser, A., Saito, S., Appella, E., Anderson, C. W., Seaman, W. T. and Kenney, S. (2002) The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol. 76, 12503-12512.
161. Montalvo, E. A., Cottam, M., Hill, S. and Wang, Y. J. (1995) YY1 binds to and regulates cisacting negative elements in the Epstein-Barr virus BZLF1 promoter. J Virol. 69, 4158-4165.
162. Montalvo, E. A., Shi, Y., Shenk, T. E. and Levine, A. J. (1991) Negative regulation of the BZLF1 promoter of Epstein-Barr virus. J Virol. 65, 3647-3655.
163. Moore, M. J. (2005) From birth to death: The complex lives of eukaryotic mRNAs. Science. 309, 1514-1518.
164. Morrison, T. E. and Kenney, S. C. (2004) BZLF1, an Epstein-Barr virus immediate-early protein, induces p65 nuclear translocation while inhibiting p65 transcriptional function. Virology. 328, 219-232.
165. Morrison, T. E., Mauser, A., Klingelhutz, A. and Kenney, S. C. (2004) Epstein-Barr virus immediate-early protein BZLF1 inhibits tumor necrosis factor alpha-induced signaling and apoptosis by downregulating tumor necrosis factor receptor 1. J Virol. 78, 544-549.
166. Morrison, T. E., Mauser, A., Wong, A., Ting, J. P. and Kenney, S. C. (2001) Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate- early protein. Immunity. 15, 787-799.
167. Nicewonger, J., Suck, G., Bloch, D. and Swaminathan, S. (2004) Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J Virol. 78, 9412-9422.
168. Niedobitek, G., Young, L. S., Lau, R., Brooks, L., Greenspan, D., Greenspan, J. S. and Rickinson, A. B. (1991) Epstein-Barr Virus Infection in Oral Hairy Leukoplakia: Virus Replication in the Absence of a Detectable Latent Phase. J Gen Virol. 72, 3035-3046.
169. Nonkwelo, C. B. and Long, W. K. (1993) Regulation of Epstein-Barr virus BamHI-H divergent promoter by DNA methylation. Virology. 197, 205-215.
170. Packham, G., Economou, A., Rooney, C. M., Rowe, D. T. and Farrell, P. J. (1990) Structure and function of the Epstein-Barr virus BZLF1 protein. J Virol. 64, 2110-2116.
171. Paulson, E. J., Fingeroth, J. D., Yates, J. L. and Speck, S. H. (2002) Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells. Virology. 299, 109-121.
172. Paulson, E. J. and Speck, S. H. (1999) Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol. 73, 9959-9968.
173. Perrine, S. P., Hermine, O., Small, T., Suarez, F., O'Reilly, R., Boulad, F., Fingeroth, J., Askin, M., Levy, A., Mentzer, S. J., Di Nicola, M., Gianni, A. M., Klein, C., Horwitz, S. and Faller, D. V. (2007) A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies. Blood. 109, 2571-2578.
174. Petosa, C., Morand, P., Baudin, F., Moulin, M., Artero, J. B. and Muller, C. W. (2006) Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein.Mol Cell. 21, 565-572.
175. Pfeffer, S., Zavolan, M., Grasser, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C. and Tuschl, T. (2004) Identification of virus-encoded microRNAs. Science. 304, 734-736.
176. Pfuller, R. and Hammerschmidt, W. (1996) Plasmid-like replicative intermediates of the Epstein-Barr virus lytic origin of DNA replication. J Virol. 70, 3423-3431.
177. Quinlivan, E. B., Holley-Guthrie, E. A., Norris, M., Gutsch, D., Bachenheimer, S. L. and Kenney, S. C. (1993) Direct BRLF1 binding is required for cooperative BZLF1/BRLF1 activation of the Epstein-Barr virus early promoter, BMRF1. Nucleic Acids Res. 21, 1999-2007.
178. Ragoczy, T., Heston, L. and Miller, G. (1998) The Epstein-Barr virus Rta protein activates lytic cycle genes and can disrupt latency in B lymphocytes. J Virol. 72, 7978-7984.
179. Ragoczy, T. and Miller, G. (2001) Autostimulation of the Epstein-Barr virus BRLF1 promoter is mediated through consensus Sp1 and Sp3 binding sites. J Virol. 75, 5240-5251.
180. Ragoczy, T. and Miller, G. (1999) Role of the epstein-barr virus RTA protein in activation of distinct classes of viral lytic cycle genes. J Virol. 73, 9858-9866.
181. Reed, R. and Cheng, H. (2005) TREX, SR proteins and export of mRNA. Curr Opin Cell Biol. 17, 269-273.
182. Reimold, A. M., Iwakoshi, N. N., Manis, J., Vallabhajosyula, P., Szomolanyi-Tsuda, E., Gravallese, E. M., Friend, D., Grusby, M. J., Alt, F. and Glimcher, L. H. (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature. 412, 300-307.
183. Rodriguez, A., Armstrong, M., Dwyer, D. and Flemington, E. (1999) Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta. J Virol. 73, 9029-9038.
184. Rodriguez, A., Jung, E. J. and Flemington, E. K. (2001) Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J Virol. 75, 4482-4489.
185. Rodriguez, A., Jung, E. J., Yin, Q., Cayrol, C. and Flemington, E. K. (2001) Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest. Virology. 284, 159-169.
186. Rooney, C. M., Rowe, D. T., Ragot, T. and Farrell, P. J. (1989) The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol. 63, 3109-3116.
187. Ruvolo, V., Gupta, A. K. and Swaminathan, S. (2001) Epstein-Barr virus SM protein interacts with mRNA in vivo and mediates a gene-specific increase in cytoplasmic mRNA. J Virol. 75, 6033-6041.
188. Ruvolo, V., Navarro, L., Sample, C. E., David, M., Sung, S. and Swaminathan, S. (2003) The Epstein-Barr virus SM protein induces STAT1 and interferon-stimulated gene expression. J Virol. 77, 3690-3701.
189. Ruvolo, V., Wang, E., Boyle, S. and Swaminathan, S. (1998) The Epstein-Barr virus nuclear protein SM is both a post-transcriptional inhibitor and activator of gene expression. Proceedings of the National Academy of Sciences of the United States of America. 95, 8852-8857.
190. Sarisky, R. T., Gao, Z., Lieberman, P. M., Fixman, E. D., Hayward, G. S. and Hayward, S. D. (1996) A replication function associated with the activation domain of the Epstein-Barr virus Zta transactivator. J Virol. 70, 8340-8347.
191. Schepers, A., Pich, D. and Hammerschmidt, W. (1993) A transcription factor with homology to the AP-1 family links RNA transcription and DNA replication in the lytic cycle of Epstein-Barr virus. Embo J. 12, 3921-3929.
192. Schepers, A., Pich, D., Mankertz, J. and Hammerschmidt, W. (1993) cis-acting elements in the lytic origin of DNA replication of Epstein-Barr virus. J Virol. 67, 4237-4245.
193. Schmaus, S., Wolf, H. and Schwarzmann, F. (2004) The reading frame BPLF1 of Epstein- Barr virus: A homologue of herpes simplex virus protein VP16. Virus Genes. 29, 267-277.
194. Sciabica, K. S., Dai, Q. J. and Sandri-Goldin, R. M. (2003) ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. Embo J. 22, 1608-1619.
195. Semmes, O. J., Chen, L., Sarisky, R. T., Gao, Z., Zhong, L. and Hayward, S. D. (1998) Mta has properties of an RNA export protein and increases cytoplasmic accumulation of Epstein-Barr virus replication gene mRNA. J Virol. 72, 9526-9534.
196. Seto, E., Yang, L., Middeldorp, J., Sheen, T.-S., Chen, J.-Y., Fukayama, M., Eizuru, Y., Ooka, T. and Takada, K. (2005) Epstein-Barr virus (EBV)-encoded BARF1 gene is expressed in nasopharyngeal carcinoma and EBV-associated gastric carcinoma tissues in the absence of lytic gene expression. J Medical Virol. 76, 82-88.
197. Sheaffer, A. K., Newcomb, W. W., Gao, M., Yu, D., Weller, S. K., Brown, J. C. and Tenney, D. J. (2001) Herpes Simplex Virus DNA Cleavage and Packaging Proteins Associate with the Procapsid prior to Its Maturation. J. Virol. 75, 687-698.
198. Sheng, W., Decaussin, G., Ligout, A., Takada, K. and Ooka, T. (2003) Malignant transformation of Epstein-Barr virus-negative Akata cells by introduction of the BARF1 gene carried by Epstein-Barr virus. J Virol. 77, 3859-3865.
199. Shimizu, N., Sakuma, S., Ono, Y. and Takada, K. (1989) Identification of an enhancer-type sequence that is responsive to Z and R trans-activators of Epstein-Barr virus. Virology. 172, 655-658.
200. Sinclair, A. J., Brimmell, M., Shanahan, F. and Farrell, P. J. (1991) Pathways of activation of the Epstein-Barr virus productive cycle. J Virol. 65, 2237-2244.
201. Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G. and Rickinson, A. B. (1997) Immediate early and early lytic cycle proteins are frequent targets of the Epstein- Barr virus-induced cytotoxic T cell response. J Exp Med. 185, 1605-1617.
202. Strockbine, L. D., Cohen, J. I., Farrah, T., Lyman, S. D., Wagener, F., DuBose, R. F., Armitage, R. J. and Spriggs, M. K. (1998) The Epstein-Barr Virus BARF1 Gene Encodes a Novel, Soluble Colony-Stimulating Factor-1 Receptor. J. Virol. 72, 4015-4021.
203. Swaminathan, S. (2005) Post-transcriptional gene regulation by gamma herpesviruses. Journal of cellular biochemistry. 95, 698-711.
204. Swaminathan, S., Hesselton, R., Sullivan, J. and Kieff, E. (1993) Epstein-Barr virus recombinants with specifically mutated BCRF1 genes. J. Virol. 67, 7406-7413.
205. Swenson, J. J., Holley-Guthrie, E. and Kenney, S. C. (2001) Epstein-Barr virus immediateearly protein BRLF1 interacts with CBP, promoting enhanced BRLF1 transactivation. J Virol. 75, 6228-6234.
206. Swenson, J. J., Mauser, A. E., Kaufmann, W. K. and Kenney, S. C. (1999) The Epstein-Barr virus protein BRLF1 activates S phase entry through E2F1 induction. J Virol. 73, 6540-6550.
207. Szyf, M., Eliasson, L., Mann, V., Klein, G. and Razin, A. (1985) Cellular and viral DNA hypomethylation associated with induction of Epstein-Barr virus lytic cycle. Proc Natl Acad Sci USA. 82, 8090-8094.
208. Takada, K. and Ono, Y. (1989) Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. J. Virol. 63, 445-449.
209. Takada, K., Shimizu, N., Sakuma, S. and Ono, Y. (1986) Trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol. 57, 1016-1022.
210. Takagi, S., Takada, K. and Sairenji, T. (1991) Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology. 185, 309-315.
211. Tarodi, B., Subramanian, T. and Chinnadurai, G. (1994) Epstein-Barr virus BHRF1 protein protects against cell death induced by DNA-damaging agents and heterologous viral infection. Virology. 201, 404-407.
212. Urier, G., Buisson, M., Chambard, P. and Sergeant, A. (1989) The Epstein-Barr virus early protein EB1 activates transcription from different responsive elements including AP-1 binding sites. Embo J. 8, 1447-1453.
213. Vieira, P., de Waal-Malefyt, R., Dang, M., Johnson, K., Kastelein, R., Fiorentino, D., deVries, J., Roncarolo, M., Mosmann, T. and Moore, K. (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRF1. Proc Natl. Acad. Sci. USA. 88, 1172-1176.
214. Wang, P., Day, L. and Lieberman, P. M. (2006) Multivalent sequence recognition by Epstein- Barr virus Zta requires cysteine 171 and an extension of the canonical B-ZIP domain. J Virol. 80, 10942-10949.
215. Wen, W., Iwakiri, D., Yamamoto, K., Maruo, S., Kanda, T. and Takada, K. (2007) Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes. J Virol. 81, 1037-1042.
216. Westphal, E. M., Mauser, A., Swenson, J., Davis, M. G., Talarico, C. L. and Kenney, S. C. (1999) Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Cancer Res. 59, 1485-1491.
217. Winkler, M., Rice, S. A. and Stamminger, T. (1994) UL69 of Human Cytomegalovirus, an open reading frame with homology to ICP27 of Herpes simplex virus, encodes a transactivator of gene expression. J. Virol. 68, 3943-3954.
218. Wu, F. Y., Chen, H., Wang, S. E., ApRhys, C. M., Liao, G., Fujimuro, M., Farrell, C. J., Huang, J., Hayward, S. D. and Hayward, G. S. (2003) CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle. J Virol. 77, 1481-1500.
219. Yokoyama, N., Fujii, K., Hirata, M., Tamai, K., Kiyono, T., Kuzushima, K., Nishiyama, Y., Fujita, M. and Tsurumi, T. (1999) Assembly of the epstein-barr virus BBLF4, BSLF1 and BBLF2/3 proteins and their interactive properties. J Gen Virol. 80 (Pt 11), 2879-2887.
220. Yoshizaki, T., Sato, H., Murono, S., Pagano, J. S. and Furukawa, M. (1999) Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator. Clin Exp Metastasis. 17, 431-436.
221. Yuan, J., Cahir-McFarland, E., Zhao, B. and Kieff, E. (2006) Virus and cell RNAs expressed during Epstein-Barr virus replication. J Virol. 80, 2548-2565.
222. Zacny, V. L., Wilson, J. and Pagano, J. S. (1998) The Epstein-Barr virus immediate-early gene product, BRLF1, interacts with the retinoblastoma protein during the viral lytic cycle. J Virol. 72, 8043-8051.
223. Zalani, S., Coppage, A., Holley-Guthrie, E. and Kenney, S. (1997) The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter. J Virol. 71, 3268-3274.
224. Zalani, S., Holley-Guthrie, E. and Kenney, S. (1996) Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc Natl Acad Sci USA. 93, 9194-9199.
225. Zalani, S., Holley-Guthrie, E. and Kenney, S. (1995) The Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter. J Virol. 69, 3816-3823.
226. Zalani, S., Holley-Guthrie, E. A., Gutsch, D. E. and Kenney, S. C. (1992) The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J Virol. 66, 7282-7292.
227. Zerby, D., Chen, C. J., Poon, E., Lee, D., Shiekhattar, R. and Lieberman, P. M. (1999) The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus. Mol Cell Biol. 19, 1617-1626.
228. Zetterberg, H., Jansson, A., Rymo, L., Chen, F., Karlsson, A., Klein, G. and Brodin, B. (2002) The Epstein-Barr virus ZEBRA protein activates transcription from the early lytic F promoter by binding to a promoter-proximal AP-1-like site. J Gen Virol. 83, 2007-2014.
229. Zhang, C. X., Decaussin, G., Daillie, J. and Ooka, T. (1988) Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells. J Virol. 62, 1862-1869.
230. Zhang, Q., Gutsch, D. and Kenney, S. (1994) Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency. Mol Cell Biol. 14, 1929-1938.
231. Zhang, Q., Hong, Y., Dorsky, D., Holley-Guthrie, E., Zalani, S., Elshiekh, N. A., Kiehl, A., Le, T. and Kenney, S. (1996) Functional and physical interactions between the Epstein- Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replication. J Virol. 70, 5131-5142.
232. zur Hausen, H., O'Neill, F. J., Freese, U. K. and Hecker, E. (1978) Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature. 272, 373-375.